Order Article Reprints

Wischnewsky M, Schwentner L, Diessner J, de Gregorio A, Joukhadar R, Davut D, Salmen J, Bekes I, Kiesel M, Müller-Reiter M, et al. BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients. Cancers. 2021; 13(13):3121. https://doi.org/10.3390/cancers13133121

Wischnewsky, Manfred, Lukas Schwentner, Joachim Diessner, Amelie de Gregorio, Ralf Joukhadar, Dayan Davut, Jessica Salmen, Inga Bekes, Matthias Kiesel, Max Müller-Reiter, and et al. 2021. "BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients" Cancers 13, no. 13: 3121. https://doi.org/10.3390/cancers13133121

Wischnewsky, M., Schwentner, L., Diessner, J., de Gregorio, A., Joukhadar, R., Davut, D., Salmen, J., Bekes, I., Kiesel, M., Müller-Reiter, M., Blettner, M., Wolters, R., Janni, W., Kreienberg, R., Wöckel, A., & Ebner, F. (2021). BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients. Cancers, 13(13), 3121. https://doi.org/10.3390/cancers13133121